← Leaderboards
Humberto Contreras-Trujillo
University Of Southern California
$130,443
Attributed
$130,443
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $44K · FY2016–18$50K$37.5K$25K$12.5K$0
'16
'17
'18
Funding mix
By agency
NIH$130,443 · 1
By mechanism
F31$130,443 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Southern California
Same institution · by research overlap
- Yves A Declerck$18,916,589
- Joseph Leo Wiemels$16,840,536
- Adam De Smith$5,539,738
- Yali Dou$14,878,089
- Caryn Lerman$95,133,528
Others in their field
Top investigators on “Leukemia”
- Richard K. Wilson · Washington University$209,620,938
- David Heimbrook · Leidos Biomedical Research, Inc.$168,419,678
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,967,203
- Peter C Adamson · National Childhood Cancer Foundation$143,910,899
- Ralph Parchment · Leidos Biomedical Research, Inc.$141,315,269
- Richard L Schilsky · University Of Chicago$129,102,207
Research focus
LeukemiaLeukemia, Lymphocytic, Acute, L1Aggressive BehaviorAcute Lymphocytic LeukemiaBaseAftercareBone Marrow CellsCancer CellAntibioticsCancerousCellsChemotherapyChildhood Cancer MortalityClone CellsCommunicationDiagnosisDna Sequence AlterationDoseFallsGrowthHeterogeneityInsightIn VivoMaintenance Therapy
Grant awards (3)
Clonal Progression of Cancer Cells during Treatment of Acute Lymphoblastic Leukemia$43,957
F31 · FY2018 · CA · contact PI
Clonal Progression of Cancer Cells during Treatment of Acute Lymphoblastic Leukemia$43,477
F31 · FY2017 · CA · contact PI
Clonal Progression of Cancer Cells during Treatment of Acute Lymphoblastic Leukemia$43,009
F31 · FY2016 · CA · contact PI